Senator Investment Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-155,000
| Closed | -$15.1M | – | 134 |
|
|
2021
Q1 | $15.1M | Buy |
+155,000
| New | +$15.1M | 0.31% | 65 |
|
|
2019
Q1 | – | Sell |
-300,000
| Closed | -$21.4M | – | 43 |
|
|
2018
Q4 | $21.4M | Buy |
+300,000
| New | +$21.4M | 0.6% | 29 |
|
|
2017
Q2 | – | Sell |
-900,000
| Closed | -$39M | – | 60 |
|
|
2017
Q1 | $39M | Buy |
900,000
+25,000
| +3% | +$1.08M | 0.48% | 44 |
|
|
2016
Q4 | $33.9M | Sell |
875,000
-275,000
| -24% | -$10.6M | 0.51% | 35 |
|
|
2016
Q3 | $58.2M | Buy |
1,150,000
+300,000
| +35% | +$15.2M | 0.77% | 34 |
|
|
2016
Q2 | $38.6M | Buy |
+850,000
| New | +$38.6M | 0.62% | 39 |
|